Comparison:
Enzyme
MLN
DeFi asset management system
$6.27
-6.8% - Trading Volume(24h) 61.48% $16,464,385.51
- Circulating Market Cap$18,719,675.97 #840
- FDV$18,737,496.09
- Circulating Supply2,988,436.379 MLN
- Total Supply2,988,436.379 MLN
- All-time High $258.26 (Jan 04, 2018)
- All-time Low $1.79 (Mar 13, 2020)
- Contract Address
0xec67...1892 - Supported Exchanges
+15 - Launched Feb 2017
Analytics
Performances
Comparison
Essentials
Details
Event Calendar
Team
Financials
Fundraising
Investment
Top Holders
Trade
Open Markets
News
Related News
𝕏 Data
Follow Updates
Follow Lists
Performances
| 1h | 24h | 7d | 30d | 60d | 90d |
| 1.06% | 6.79% | 4.66% | 18.09% | 19.36% | 24.61% |
Comparison
Total Raised: --
Fundraising not disclosed
FDV: --
Token not listed
24h Trading Volume: --
Token not listed
Project Name
Enzyme
MLN
Intro
--
Total Raised
--
Core Team
--
Core Investors
--
RD Growth (7d Change%)
--
RD Impact (7d %)
--
Details
Enzyme is an easy-to-use DeFi asset management system that funds, investment clubs, DAO treasuries, and companies can plug into. It simplifies interactions with DeFi by acting as an aggregator of protocols and making users' asset management experience seamless.
Event Calendar
2017-02
MLN is live for trading
2017-02-16
Enzyme raised $ 2.9 M through ICO
2025-10-16
Share to 
Share poster
Share poster
Fundraising
Top Holders
Open Markets
--
# | Exchange | Pair | Price | +2% depth | -2% depth | Volume (24h) | volume % |
|---|---|---|---|---|---|---|---|
No Data | |||||||
𝕏 Follow Updates
No Data𝕏 Follow Lists
$6.27
-6.8% 
- Trading Volume(24h) 61.48% $16,464,385.51
- Circulating Market Cap$18,719,675.97 #840
- FDV$18,737,496.09
- Circulating Supply2,988,436.379 MLN
- Total Supply2,988,436.379 MLN
- All-time High $258.26 (Jan 04, 2018)
- All-time Low $1.79 (Mar 13, 2020)
- Total Raised $2.9M
- Contract Address 0xec67...1892
- Supported Exchanges +15
- Launched Feb 2017
Rate Enzyme
Rated by 0 users
What’s your take on Enzyme? Share your review.
Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.
